about
Pharmacology and rationale for imatinib in the treatment of sclerodermaUnveiling changes in the landscape of patient populations in cancer early drug developmentPrediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumoursCalcium carbonate does not affect nilotinib pharmacokinetics in healthy volunteers.A high-performance liquid chromatography-mass spectrometry assay for quantitation of the tyrosine kinase inhibitor nilotinib in human plasma and serum.Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.Calcium carbonate does not affect imatinib pharmacokinetics in healthy volunteersPhase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042.Therapeutic drug monitoring of imatinib for chronic myeloid leukemia patients in the chronic phase.Clinically significant drug interactions with antacids: an update.Tyrosine kinase inhibitors and drug interactions: a review with practical recommendations.Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?Interactions between oral antineoplastic agents and concomitant medication: a systematic review.Results of a phase 1, randomized study evaluating the effects of food and diurnal variation on the pharmacokinetics of linifanib.Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers.Imatinib mesylate pharmacokinetics before and after sleeve gastrectomy in a morbidly obese patient with chronic myeloid leukemia.Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.A clinical study to examine the potential effect of lansoprazole on the pharmacokinetics of bosutinib when administered concomitantly to healthy subjects.Clinical efficacy of generic imatinib
P2860
Q26825153-971E7D65-BD78-44D5-9EC0-CE01B7173675Q28073826-FEC41116-171C-4F66-BA32-63ECE5D0E520Q36729934-33D4EB1C-3670-4A41-8411-8BF719C0C499Q37281684-FD4A9000-60B8-4779-B850-ED3CC6657596Q37381751-6B4199A6-CF23-4815-B775-DECD7685F437Q37397785-336FADFB-3F05-4C91-87B6-F8A5F2952FDEQ37432684-5CF8CD44-47E2-49F4-B8F0-EBDCF7C8835AQ37549881-AD0F49DD-EA6B-4BFB-9BBD-301B8C9A02F1Q37862942-6398C48B-5133-443C-823E-199F742ED89EQ37937722-A9E69948-AB4B-47A9-A729-41FF444D6C42Q37981002-8364B1A4-5EAA-4661-A373-C254C8495036Q38022125-392CE7F9-825C-4ABF-A2E4-39E858A1B37CQ38099040-FF2F90FB-16AA-4ACA-9033-F3F399A51F34Q39196166-0C62A17E-66C0-46FD-AD53-DC578BEBE137Q40721053-13531506-0425-463E-A4A8-A912F645D621Q43288117-DE008E80-D91A-4223-8A5B-8A39990B670EQ43841175-10A9333C-9A9B-4FBA-B08D-E0B378A98351Q51337867-6ED3955B-70E1-4D2A-B9C9-2361524824DBQ57108016-67203417-B376-46F2-9963-50F2424BEE4D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of antacid on imatinib absorption
@en
Effect of antacid on imatinib absorption.
@nl
type
label
Effect of antacid on imatinib absorption
@en
Effect of antacid on imatinib absorption.
@nl
prefLabel
Effect of antacid on imatinib absorption
@en
Effect of antacid on imatinib absorption.
@nl
P2093
P2860
P1476
Effect of antacid on imatinib absorption
@en
P2093
Brian A Sparano
Jennifer Walters
Kristin A Komazec
Merrill J Egorin
Robert A Parise
Robert L Redner
P2860
P2888
P304
P356
10.1007/S00280-008-0778-7
P50
P577
2008-05-24T00:00:00Z